Avidity Biosciences Inc.

NASDAQ: RNA · Real-Time Price · USD
46.46
0.39 (0.85%)
At close: Aug 15, 2025, 3:59 PM
46.47
0.02%
After-hours: Aug 15, 2025, 04:10 PM EDT

Avidity Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-322.3M -212.22M -174M -118.01M
Depreciation & Amortization
2.78M 2.1M 1.39M 639K
Stock-Based Compensation
51.36M 38.22M 27.14M 17.06M
Other Working Capital
-49.74M 59.36M -8.5M -705K
Other Non-Cash Items
-18.15M -8.3M -615K 163K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-14.56M 61.13M 9.82M 5.34M
Operating Cash Flow
-300.87M -119.06M -136.27M -94.81M
Capital Expenditures
-7.07M -4.23M -2.82M -3.74M
Cash Acquisitions
n/a n/a 187.13M 82.52M
Purchase of Investments
-1.43B -461M -355.84M -85.36M
Sales Maturities Of Investments
586.4M 335.16M 168.71M 6.58M
Other Investing Acitivies
n/a n/a -187.13M -82.52M
Investing Cash Flow
-854.2M -130.07M -189.96M -82.52M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
191.81M 2.13M 1.39M 1.64M
Financial Cash Flow
1.19B 93.86M 346.17M 176.32M
Net Cash Flow
37.29M -155.27M 19.95M -1.01M
Free Cash Flow
-307.94M -123.29M -139.09M -98.55M